The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
18 November 2019
1) CTF
Steering Committee
Roadmap and minutes shared were shared with Steering Committee.
CTF WG1
No update.
CTF WG3
Doodle to determine dates for next call shared.
2) Policy updates
Medicines Shortages
- 2019 Medicines Shortages Survey – Greek and Slovak version published. 200 responses have been received however not all of these are complete. Outreach will continue. Reminders will be sent on 28th November
MEP outreach
- Meetings have been set up with assistant of MEP Auken, MEP Huitema (TS), MEP Knotek (PH).
- Meetings with MEP Patriciello, MEP Arłukowicz and the assistant of MEP Calenda are being scheduled.
- Some MEPs requested to receive a briefing note due to the lack of time to meet with EAHP.
- Policy team will continue to reach out to MEPs.
AMR
- EAAD 2019 – Social media campaign is ready. EAHP has analysed the results of the ECDC survey for HPs and will publish them on 18th November.
Preparation of position papers for GA
- The preparation of position papers for the GA 2020 has started. Feedback is currently awaited.
ESOP
- 3/2/2020 was offered to Klaus as alternative date. Awaiting feedback.
3) Consultations – state of play
22/11/19 | EPHA – digital health consultation | HKO prepared response with Board leads. |
4) Congress
President’s Guest meetings
The following organisations have confirmed their attendance: ASHP, EAFP, EPSA, ESCP, PGEU, ESOP, EMA, EAPT, UEPH. In addition, 3 international organisations confirmed (Organización de Farmacéuticos Ibero-Latinoamericanos; Emirates Pharmacy Society; Egyptian Foundation of Clinical Pharmacy; Societe Algerienne de Pharmacie Hospitaliere et Oncologiquie).
EDQM is still waiting for approval from their hierarchy. The EURORDIS president is not available. Could he share the invitation with another person in the organisation.
The following meetings could be considered:
- Meeting with International Organisations
- Meeting on AMR with all interested organisations
- Individual meetings – given that we need to deepen our relationship with some pharmacy organisations it should be considered to meet with them individually instead of in a larger group
Meetings with members
Members will receive an invitation to the meetings at Congress in the week of 9th November. The agenda for the FMD meeting will be finalised together with the FMD leads. On the agenda for the member meeting the point ‘communication with members’ will be added as discussed during the Board meeting. Which other points should be added?
5) Miscellaneous
HPP: Endorsement request – Improving healthcare access for marginalised people
Endorsement feedback is still being collected. The Board is currently leaning towards no.
Letter to the new Commissioner
SK will put together a letter for Stella which can be sent out after she has taken office. The draft will be shared next week with PH.
Next policy call – Beginning of December? 2nd or 5th of December?